��������

Bob Spivak currently serves as Vice President of Investment Banking at LifeSci Capital LLC, where involvement spans from May 2018 to the present with a focus on healthcare. Previously, Bob held the position of Vice President at LifeSci Acquisition II Corp., overseeing the successful merger with Science 37, Inc. Bob also served as Vice President at LifeSci Acquisition Corp., facilitating the merger with Vincerx Pharma. Earlier experiences include roles at Maxim Group, LifeSci Advisors, New York State Homes and Community Renewal, and Kforce Inc., ranging from analyst to intern positions. Bob Spivak holds a Bachelor of Business Administration in Finance and Applied Mathematics from Pace University, earned between 2015 and 2019.